This invention provides an improved method for producing a novel interfacing capillary device that is less costly and more durable than existing sheathless devices. This simplified production method does not require sample dilution, etching, or precision hand tools, and is automated and reproducible.
This invention is a molecular screen to predict which patients’ non-invasive breast tumors will eventually progress to invasive breast cancers.
The current invention concerns the novel use of an endogenous estrogen derivative that has a super-strong neuroprotective effect against oxidative neurotoxicity in vivo.
A microfluidic device capable of efficiently isolating exosomes from blood and plasma.
The invention offers novel composition of matter to be used in treatment of a number of hormone responsive cancers.
A novel method of inducing adult-derived stem cell proliferation in tissue from adult animals. Harvested embryonic, pluripotent or more differentiated stem cells may be used in cell therapy, tissue engineering, or other medical, veterinary, and industrial applications.
The invention provides a "sample-in-answer-out" microfluidic exosome profiling platform which integrates immunoaffinity isolation of plasma exosomes with quantitative detection of both surface and intravesicular markers for characterization of exosomal phenotypes.
This invention uses microRNA biomarkers to detect or diagnose Barrett's esophagus, detect dysplasia in Barrett's esophagus, and detect early onset of esophageal cancer.